| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0008 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |